1.20

0.00% 0.00

Silo Pharma Inc (SILO)

Overview News Price History Financials Discussions Forecast Stock Split

Silo Pharma Inc stock is traded at $1.20, with a volume of 14,094. It is up +0.00% in the last 24 hours and down -38.14% over the past month. SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

Previous Close:

$1.20

Open:

$1.2

24h Volume:

14,094

Relative Volume:

0.08

Market Cap:

$2.46M

Revenue:

$72,100

Net Income/Loss:

$-4.84M

P/E Ratio:

-0.1609

EPS:

-7.4566

Net Cash Flow:

$-3.84M

1W Performance:

-17.24%

1M Performance:

-38.14%

6M Performance:

-80.46%

1Y Performance:

-87.88%

1-Day Range:

$1.15

$1.235

1-Week Range:

$1.10

$1.49

52-Week Range:

$1.10

$10.43

Silo Pharma Inc Stock (SILO) Company Profile

Name

Silo Pharma Inc

Sector

Healthcare (1051)

Industry

Biotechnology (593)

Phone

(718) 400-9031

Address

677 N. WASHINGTON BLVD, SARASOTA

Employee

Twitter

Next Earnings Date

2026-11-12

Latest SEC Filings

SILO's Discussions on Twitter

Compare SILO vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SILO Silo Pharma Inc	1.20	2.46M	72,100	-4.84M	-3.84M	-7.4566
VRTX Vertex Pharmaceuticals Inc	508.75	128.95B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	236.50	94.42B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	796.34	81.99B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	846.27	53.22B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	374.08	42.32B	5.76B	514.49M	1.10B	4.4813

Silo Pharma Inc Stock (SILO) Latest News

Oct 03, 2026

Silo Pharma Acquires IP Assets in Strategic Agreement - The Globe and Mail

Oct 03, 2026

Oct 02, 2026

A warrant for up to 300,000 shares is Silo Pharma (SILO)'s payment for software assets. - Stock Titan

Oct 02, 2026

Sep 30, 2026

NVIDIA models join QwikAgents, which adds a second software option for AI assistants. - Stock Titan

Sep 30, 2026

Sep 24, 2026

Why Is Silo Pharma (NASDAQ:SILO) Moving Into Focus? - Kalkine Media

Sep 24, 2026

Sep 18, 2026

Silo Pharma Inc (NASDAQ: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - kalkine.com.au

Sep 18, 2026

Sep 09, 2026

Silo Pharma Highlights Patented Nose-To-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum - marketscreener.com

Sep 09, 2026

Silo Pharma to Present at IPAC-RS 2026 Nasal Innovation Forum, Highlighting Progress of PTSD Candidate SPC-15 - citybuzz -

Sep 09, 2026

Silo Pharma to Participate in IPAC-RS 2026 Nasal Innovation Forum as It Advances SPC-15 Development - Quiver Quantitative

Sep 09, 2026

A nasal PTSD treatment met specs for nine months - Stock Titan

Sep 09, 2026

Sep 04, 2026

Silo Pharma Stock Price Forecast. Should You Buy SILO? - StockInvest.us

Sep 04, 2026

Silo Pharma Inc (NYSE: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - Kalkine

Sep 04, 2026

Aug 29, 2026